… Gastric cancer remains frequent and one of the most lethal … insights in the therapeutic
management of gastric cancer, with … , adjuvant chemo-radiation therapy or adjuvant chemotherapy …

… National guidelines recommend a multidisciplinary team approach to therapeutic
decisions for patients with gastric cancer. Meetings are encouraged at least once a week with …

… have been/are in targeted therapy clinical trials and, which as … Some gastric cancer biomarkers
that may help in defining … therapies may improve gastric cancer patients’ outcome, but are …

… Targeted therapies licensed to treat gastric cancer include trastuzumab (HER2-positive
patients first line), ramucirumab (anti-angiogenic second line), and nivolumab or pembrolizumab …

… Although chemotherapy has been the backbone therapy for advanced gastric cancer for … to
be the standard first-line therapy for HER2-positive gastric cancer. The anti-VEGFR2 inhibitor, …

… Since the 1970s, gastric cancer therapy has steadily improved with chemotherapeutic
regimens administered in either doublet or triplet combinations. A timeline of recent treatment …

… Molecular classification based on HER2 (also known as ERBB2) status was introduced for
gastric cancers because of therapeutic implications. HER2, which is a member of the human …

… Core tip: Surgery remains the only curative therapy of localized gastric cancer, while
perioperative and adjuvant chemotherapy, as well as chemoradiation, can improve outcome. …

… In the present study, the only predictors of a more favorable outcome after resection of
gastric cancer with therapeutic intent in the setting of metastatic disease known prior to surgery …

… biopsies; (iii) the prognostication among those with established gastric cancer; iv) the
therapeutic outcomes in localized, or metastatic and unresectable gastric cancer. …